Department News | January 28, 2026
Earlier this month, the Center for Novel Therapeutics in Addiction Psychiatry (NTAP) joined the Addictions, Drug & Alcohol Institute (ADAI).
News & Stories
Video — What to expect when a loved one is receiving care at CBHL
Department News | January 28, 2026
Supporting a loved one with a serious mental illness can be hard, particularly if they need to be hospitalized, so we produced this short video, narrated by FACTS Director Mollie Forrester, MSW, LICSW, to help families and caregivers navigate this journey and let them know what to expect when their loved one is receiving care at the CBHL.
History of trauma linked to risk of long COVID
UW Medicine Newsroom | January 21, 2026
A study led by Rebecca Hendrickson, MD, PhD found persistent COVID-19 symptoms after infection are more likely in people who have experienced traumatic stress.
Psychedelics in Seattle
UW Daily | January 5, 2026
Nathan Sackett, PhD leads a clinical trial using psilocybin to treat PTSD and alcohol abuse disorder among veterans and first responders.
New faculty to focus on digital innovation and artificial intelligence
Department News | November 26, 2025
We’re happy to announce that Devon Sandel-Fernandez, PhD and Adam Kuczynski, PhD have been selected to lead our department’s efforts in digital innovation and artificial intelligence.
Psilocybin clinical trial underway
Department News | October 30, 2025
Led by Nathan Sackett, MD, MS, PsiloStudy has already learned a lot about the safety and experience of those treated with psilocybin and psychological support.
Recruiting two new endowed positions
Department News | May 29, 2025
We are now happy to begin recruiting for two new endowed positions supported by generous philanthropic support, one with a focus on addiction psychiatry and another with a focus on adult cognitive aging.
CSTP awards over $180K in research funding to trainees
Department News | May 14, 2025
We are pleased to announce our third year of Trainee Research Awards, part of the Clinician Scientist Training Program (CSTP). These awards support the development of clinician scientists and provide funding and faculty support for trainees to participate in mentored research.
Washington cities are decriminalizing magic mushrooms. Could a psychedelic ‘renaissance’ take hold statewide?
KUOW | May 13, 2025
Nathan Sackett, MD's trial is the first to look at whether psilocybin-assisted therapy can help people who suffer from both post-traumatic stress disorder and alcohol use disorder.
Fellowship program prepares brain doctors of the future
Department News | April 30, 2025
A new, interdisciplinary fellowship program supported by the Garvey Institute for Brain Health Solutions is bridging the gap between neurology and psychiatry, allowing healthcare professionals to better understand the complex relationship between brain function and behavior.